Connect
MJA

Risks and realities of single vial antivenom recommendations for envenoming by Australian elapid snakes

Geoffrey K Isbister and Nicholas A Buckley
Med J Aust 2020; 213 (1): . || doi: 10.5694/mja2.50652
Published online: 6 July 2020

To the Editor: We read the perspective by Weinstein and colleagues1 with interest and agree that treatment of snake envenoming in Australia is complex, and that clinicians should seek expert advice in cases of severe or unusual envenoming. There is 24‐hour specialist clinical toxicologist support available through the national Poisons Information Centre network (13 11 26), which takes 300 calls annually regarding snakebite.

  • Geoffrey K Isbister1,2
  • Nicholas A Buckley3

  • 1 Clinical Toxicology Research Group, University of Newcastle, Newcastle, NSW
  • 2 Calvary Mater Newcastle, Newcastle, NSW
  • 3 University of Sydney, Sydney, NSW

Correspondence: geoff.isbister@gmail.com

Acknowledgements: 

Geoffrey Isbister is funded by National Health and Medical Research Council Senior Research Fellowship 1061041.

Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.